Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Gabriel Wasinger"'
Publikováno v:
Anatomia, Vol 2, Iss 3, Pp 253-260 (2023)
Tumor staging of prostate cancer is a fundamental principle in management and therapy, with a hallmark being tumor growth beyond the organ boundary. Often, this is referred to as “capsule penetration”, suggesting the existence of a true prostatic
Externí odkaz:
https://doaj.org/article/e1310faf8cb24ac8bdffdf180bc50386
Publikováno v:
Cancers, Vol 16, Iss 11, p 2002 (2024)
Over the years, our understanding of cribriform and intraductal prostate cancer (PCa) has evolved significantly, leading to substantial changes in their classification and clinical management. This review discusses the histopathological disparities b
Externí odkaz:
https://doaj.org/article/4937e5c6304442f7b8f346310dcae442
Publikováno v:
Cancers, Vol 16, Iss 9, p 1650 (2024)
Intraductal carcinoma of the prostate (IDC-P) has emerged as a distinct entity with significant clinical implications in prostate cancer (PCa) management. Despite historically being considered an extension of invasive PCa, IDC-P shows unique biologic
Externí odkaz:
https://doaj.org/article/a2d0d19e2f4647a1910362e92bacce89
Autor:
Florian A. Büttner, Stefan Winter, Viktoria Stühler, Steffen Rausch, Jörg Hennenlotter, Susanne Füssel, Stefan Zastrow, Matthias Meinhardt, Marieta Toma, Carmen Jerónimo, Rui Henrique, Vera Miranda-Gonçalves, Nils Kröger, Silvia Ribback, Arndt Hartmann, Abbas Agaimy, Christine Stöhr, Iris Polifka, Falko Fend, Marcus Scharpf, Eva Comperat, Gabriel Wasinger, Holger Moch, Arnulf Stenzl, Marco Gerlinger, Jens Bedke, Matthias Schwab, Elke Schaeffeler
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-19 (2022)
Abstract Background Renal cell carcinoma (RCC) is a heterogeneous disease comprising histologically defined subtypes. For therapy selection, precise subtype identification and individualized prognosis are mandatory, but currently limited. Our aim was
Externí odkaz:
https://doaj.org/article/876bc134c9284335b9606279982c1274
Autor:
Eva Compérat, Gabriel Wasinger, André Oszwald, Renate Kain, Geraldine Cancel-Tassin, Olivier Cussenot
Publikováno v:
Genes, Vol 11, Iss 12, p 1396 (2020)
Prostate cancer (PCa) is a major concern in public health, with many genetically distinct subsets. Genomic alterations in PCa are extraordinarily complex, and both germline and somatic mutations are of great importance in the development of this tumo
Externí odkaz:
https://doaj.org/article/bb1abffc1af845d0859a6dbf6c91e95b
Publikováno v:
Current Opinion in Urology. 33:239-244
Publikováno v:
Surgical Pathology Clinics. 15:629-640
Autor:
Iris E. Ertl, Ursula Lemberger, Dafina Ilijazi, Melanie R. Hassler, Andreas Bruchbacher, Robert Brettner, Hannah Kronabitter, Michael Gutmann, Petra Vician, Gerhard Zeitler, Anna Koren, Charles-Hugues Lardeau, Thomas Mohr, Andrea Haitel, Eva Compérat, André Oszwald, Gabriel Wasinger, Thomas Clozel, Olivier Elemento, Stefan Kubicek, Walter Berger, Shahrokh F. Shariat
Publikováno v:
European Urology. 82:261-270
The heterogeneity of bladder cancers (BCs) is a major challenge for the development of novel therapies. However, given the high rates of recurrence and/or treatment failure, the identification of effective therapeutic strategies is an urgent clinical
Autor:
Eva Compérat, André Oszwald, Gabriel Wasinger, Johannes Kläger, Melanie R. Hassler, Shahrokh F. Shariat
Publikováno v:
Current Opinion in Urology. 32:451-455
To highlight the latest changes in prostate cancer (PCa), urothelial carcinoma, upper tract urothelial carcinoma (UTUC) and renal cell carcinoma (RCC) diagnosis and the impact of genetics in this field.Breast cancer1/2 mutations start to play a major
Publikováno v:
Current Opinion in Urology. 32:511-516
Six years after the release of the 4th edition of the WHO classification on male and genitourinary tumors in 2016, the upcoming 5th edition will be released in 2022. This review will discuss significant changes in the new WHO classification for uroth